Quoted Micro 23 March 2026
AQUIS STOCK EXCHANGE Brewer Shepherd Neame (SHEP) reported flat interim revenues and pre-tax profit of £84.7m and £4.2m respectively. Net debt is £84.7m and a £1m share buyback is planned. The dividend has been raised 3% to 4.5p/share. NAV is 1234p/share. Pubs traded strongly and that offset lower brewing volumes, which fell 6.6% representing a […]
Quoted Micro 26 January 2026
AQUIS STOCK EXCHANGE Cardiometabolic health products developer ProBiotix Health (PBX) increased sales by 45% to £2.72m in 2025 and reduced the loss. During the year, ProBiotix entered the Korean market and submitted applications for two new clinical trials. There was £1.27m in the bank at the end of £1.27m. The order book is worth £1.3m. […]
Quoted Micro 15 December 2025
AQUIS STOCK EXCHANGE Greengage and Co Group plans to join the Access segment of Aquis in mid-December. It has developed a fintech platform that provides business-to-business introductions which generates subscriptions and fees. There are more than 40 active clients. The strategy is to expand this part of the business and buy Bitcoin to establish a […]
Quoted Micro 22 September 2025
AQUIS STOCK EXCHANGE Vehicle electrification technology developer Equipmake (EQIP) has received a £5.45m order from Agrale to supply electric drivetrain systems for 50 buses. Agrale had previously ordered five drivetrains. The new order will be delivered from now to mid-2026 and there will be payments in advance for each delivery. Equipmake has an order book […]
Quoted Micro 21 July 2025
AQUIS STOCK EXCHANGE Probiotics developer ProBiotix Health (LON: PBX) increased interim revenues by one-third to £1.34m and the loss was reduced. The first orders have been delivered to Kemin China Technology. The current order book is at record levels. There was £1.3m in cash at the end of June 2025. The full interims will be […]
Quoted Micro 23 September 2024
AQUIS STOCK EXCHANGE Digital assets investor KR1 (KR1) reported interim revenues from those digital assets improving from £3.91m to £8.72m, although lower gains on disposals of assets meant that the pre-tax profit edged up from £10m to £10.3m. There was £1.5m in cash in the balance sheet at the end of June 2024. NAV was […]
Quoted Micro 25 September 2023
AQUIS STOCK EXCHANGE Aquis Stock Exchange owner Aquis Exchange (AQX) reported interims showing growth in all four divisions of the group and the Aquis Stock Exchange remains profitable. Group revenues improved from £7.85m to £9.34m, while pre-tax profit rose from £699,000 to £1.15m. Net cash is £13.9m. Brewer Adnams (ADB) says trading improved in the […]
Quoted Micro 28 August 2023
AQUIS STOCK EXCHANGE Pharma C Investments (PCIL) has received a general meeting requisition from one of its shareholders. The directors are reviewing the request. Technology marketing start-up Inteliqo (IQO) generated income of more than $400,000 and pre-tax profit of $250,000 from the distribution rights of the Langaroo app, which has still to be launched on […]
Quoted Micro 20 March 2023
AQUIS STOCK EXCHANGE MBH Corporation (LON: MBH) joined the Access segment of the Aquis Stock Exchange on 13 March. The shares have previously been traded on the Frankfurt Stock Exchange and the Dusseldorf Stock Exchange. Trading started on Aquis at 7p (5p/9p) and it stayed at that price all week. There were no trades. MBH […]
Quoted Micro 21 November 2022
AQUIS STOCK EXCHANGE EDX Medical (EDX) completed its reversal into shell TECC Capital in a deal valued at £12m and £1.2m was raised at 6p a share. The share price returned from suspension and increased by 64.1% to 5.25p, but it is still below the placing price. EDX Medical develops digital diagnostic products and service […]